Cytogen Corporation

650 College Road East
Princeton
New Jersey
08540
United States

Tel: 609-750-8200
Fax: 609-452-2476

Email: cytoinfo@corpcomm.cytogen.com

Show jobs for this employer

About Cytogen Corporation

Cytogen Corporation is a biopharmaceutical company with an established and growing product line in prostate cancer and other areas of oncology. Currently marketed products include ProstaScintâ (a monoclonal antibody-based imaging agent used to image the extent and spread of prostate cancer); BrachySeedä I-125 and Pd-103 (two uniquely designed next generation radioactive seed implants for the treatment of localized prostate cancer), and Quadrametâ (a skeletal targeting therapeutic radiopharmaceutical marketed for the relief of bone pain in prostate and other types of cancer). Cytogen is evolving a pipeline of oncology product candidates by developing its prostate specific membrane antigen, or PSMA, technologies, which are exclusively licensed from Memorial Sloan-Kettering Cancer Center. AxCell Biosciences of Newtown, PA, a subsidiary of Cytogen Corporation, is engaged in the research and development of novel biopharmaceutical products using its portfolio of functional proteomics solutions and collection of proprietary signal transduction pathway information.
Last Updated: 10-16-02

100 articles about Cytogen Corporation